# Study of SLN12140 in Healthy Adult Participants

> **NCT06945445** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Linno Pharmaceuticals, Inc.** · enrollment: 56 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** SLN12140
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06945445
- **Lead sponsor:** Linno Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04
- **Primary completion:** 2026-05
- **Final completion:** 2026-06
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2025-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06945445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06945445, "Study of SLN12140 in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06945445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*